Theodore Friedmann

Theodore Friedmann's AcademicInfluence.com Rankings

Theodore Friedmann

Philosophy

#6662

World Rank

#9730

Historical Rank

Logic

#3793

World Rank

#5003

Historical Rank

philosophy Degrees

Theodore Friedmann

Biology

#9021

World Rank

#12176

Historical Rank

Virology

#205

World Rank

#211

Historical Rank

Biochemistry

#1345

World Rank

#1466

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Theodore Friedmann's Degrees

Masters Medicine University of Pennsylvania
PhD Biochemistry University of Pennsylvania

Why Is Theodore Friedmann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Theodore Friedmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. (1993) (1418)
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. (1988) (818)
The nucleotide sequence of bacteriophage φX174 (1978) (539)
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. (1994) (522)
Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. (1988) (498)
Base sequence studies of 300 nucleotide renatured repeated human DNA clones. (1981) (485)
Generation of high-titer pseudotyped retroviral vectors with very broad host range. (1994) (480)
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence (1986) (371)
Progress toward human gene therapy. (1989) (341)
Analysis of the p53 gene and its expression in human glioblastoma cells. (1994) (340)
Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1 (1992) (296)
Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus (1991) (292)
Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. (1994) (290)
Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences (1980) (266)
Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. (1984) (262)
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. (1989) (251)
Isolation and Characterization of a Full-Length Expressible cDNA for Human Hypoxanthine Phosphoribosyltransferase (1983) (237)
A brief history of gene therapy (1992) (210)
Grafting genetically modified cells to the brain: Possibilities for the future (1987) (208)
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. (1983) (174)
Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. (1983) (168)
Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells (1981) (156)
Expression of a retrovirus encoding human HPRT in mice. (1984) (153)
Overcoming the obstacles to gene therapy. (1997) (146)
Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function (1994) (137)
THE DEVELOPMENT OF HUMAN GENE THERAPY (1999) (132)
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. (1989) (129)
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease (1994) (122)
Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. (1997) (121)
Gene expression from transcriptionally disabled retroviral vectors. (1987) (119)
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. (1988) (117)
Grafting genetically modified cells into the rat brain: characteristics of E. coli beta-galactosidase as a reporter gene. (1989) (109)
Human gene therapy — an immature genie, but certainly out of the bottle (1996) (107)
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. (2011) (106)
Adenovirus vector infection of chronic lymphocytic leukemia B cells. (1996) (101)
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. (1982) (97)
The nucleotide sequence and genome organization of the polyoma early region: Extensive nucleotide and amino acid homology with SV40 (1979) (95)
The organization of the human HPRT gene. (1986) (95)
Concepts and strategies for human gene therapy. (1992) (88)
Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector. (1984) (85)
Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase III. (1981) (83)
Grafting genetically modified cells to the brain: conceptual and technical issues. (1990) (81)
Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. (1996) (80)
Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. (1985) (79)
Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes. (1987) (77)
The nucleotide sequence of bacteriophage phiX174. (1978) (76)
Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. (2002) (76)
Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. (1992) (75)
Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. (1992) (74)
Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system (1996) (72)
Pseudotyped retroviral vectors for studies of human gene therapy (1995) (69)
Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype (1991) (67)
Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. (1992) (63)
Metabolic Cooperation between Genetically Marked Human Fibroblasts in Tissue Culture (1968) (62)
Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle (1992) (61)
Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. (1995) (60)
Gene therapy for neurological disorders. (1994) (60)
The nucleotide sequence and restriction enzyme sites of the polyoma genome. (1980) (59)
Influence of Age and Strain on Striatal Dopamine Loss in a Genetic Mouse Model of Lesch‐Nyhan Disease (1999) (58)
Principles for Human Gene Therapy Studies (2000) (57)
Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA (1984) (56)
Amino acid sequence homology between polyoma and SV40 tumour antigens deduced from nucleotide sequences (1978) (55)
High-efficiency gene transfer into cells. (1987) (54)
Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. (1983) (54)
Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. (1992) (54)
Brain Purines in a Genetic Mouse Model of Lesch‐Nyhan Disease (1993) (53)
Effect of Host Modification and Age on Airway Epithelial Gene Transfer Mediated by a Murine Leukemia Virus-Derived Vector (1998) (51)
Gene therapy of cancer through restoration of tumor‐suppressor functions? (1992) (51)
Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro. (1988) (50)
Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. (2012) (50)
Pantropic retroviral vector-mediated gene transfer, integration, and expression in cultured newt limb cells. (1994) (50)
Enhanced Gene Transfer with Fusogenic Liposomes Containing Vesicular Stomatitis Virus G Glycoprotein (1998) (49)
Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector. (1996) (49)
Animal models of Lesch-Nyhan syndrome (1990) (48)
ASGCT and JSGT Joint Position Statement on Human Genomic Editing. (2015) (46)
Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. (2002) (45)
Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome. (1991) (45)
Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol. (1970) (44)
Separable Mechanisms of Attachment and Cell Uptake during Retrovirus Infection (2000) (43)
Structural Roles of Polyoma Virus Proteins (1972) (43)
Efficient gene expression in mammalian cells from a dicistronic transcriptional unit in an improved retroviral vector. (1991) (43)
Dose-related analgesic effects of flupirtine. (1991) (42)
Gene doping in sports: the science and ethics of genetically modified athletes. (2011) (41)
Variable stability of a selectable provirus after retroviral vector gene transfer into human cells (1986) (40)
Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis. (2010) (40)
Evidence against the existence of guanosine and inosine kinases in human fibroblasts in tissue culture. (1969) (40)
Nucleotide sequence and genetic organization of the polyoma late region: Features common to the polyoma early region and SV40 (1979) (39)
The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation (2013) (39)
Nucleotide sequence studies of polyoma DNA. The Hpa II 3/5 junction to the Hpa II 4/Hae III 18 junction, encoding the origin of DNA replication and the 5' end of the early region. (1978) (39)
Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase (2012) (39)
Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. (1997) (38)
HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? (2011) (38)
The structure of acetylcholinesterase: relationship to its function and cellular disposition (1987) (36)
In Vitro Cell-Free Conversion of Noninfectious Moloney Retrovirus Particles to an Infectious Form by the Addition of the Vesicular Stomatitis Virus Surrogate Envelope G Protein (1998) (35)
MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease? (2012) (34)
Gene Doping and Sport (2010) (34)
Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors. (1995) (32)
Autocrine differentiation of PC12 cells mediated by retroviral vectors. (1990) (31)
A Scientific Perspective (2006) (31)
Post-transcriptional regulation of retroviral vector-transduced low density lipoprotein receptor activity. (1990) (31)
Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein. (1993) (31)
VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection. (2001) (31)
In vitro reassembly of shell-like particles from disrupted polyoma virus. (1971) (30)
Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype. (2004) (30)
Gene therapy in the CNS: intracerebral grafting of genetically modified cells. (1990) (30)
Polybrene increases the efficiency of gene transfer by lipofection (1998) (30)
Relative quantitative assay of the biological activity of interferon messenger ribonucleic acid. (1975) (28)
Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175 (1991) (28)
Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein. (2005) (28)
Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization (1992) (26)
Mechanisms of Action of the p53 Tumor Suppressor and Prospects for Cancer Gene Therapy by Reconstitution of p53 Function (1994) (26)
Nucleotide sequences at the termini of phi 29 DNA. (1981) (25)
The human genome project--some implications of extensive "reverse genetic" medicine. (1990) (25)
Swimming behavior of X and Y human sperm. (1984) (25)
Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice. (2000) (25)
Gene transfer : delivery and expression of DNA and RNA : a laboratory manual (2007) (24)
Transduction of a Drug-Sensitive Toxic Gene into Human Leukemia Cell Lines with a Novel Retroviral Vector (1993) (23)
Stanfield Rogers: insights into virus vectors and failure of an early gene therapy model. (2001) (23)
Effects of Choline and Quiescence on Drosophila Choline Acetyltransferase Expression and Acetylcholine Production by Transduced Rat Fibroblasts (1992) (23)
Genetic economy of polyoma virus: capsid proteins are cleavage products of same viral gene. (1974) (22)
Retrovirus vector-mediated gene transfer into hepatocytes. (1989) (21)
Gene transfer and athletics- an impending problem. (2001) (21)
Gene therapy and the brain. (1995) (21)
Tissue-specific aberrations of gene expression in HPRT-deficient mice: functional complexity in a monogenic disease? (2007) (20)
Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection. (1996) (20)
Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles. (1994) (20)
Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts (2008) (19)
Structural proteins of polyoma virus: proteolytic degradation of virion proteins by exogenous and by virion-associated proteases (1976) (18)
How Close Are We to Gene Doping? (2010) (18)
Association of Murine Leukemia Virus Pol with Virions, Independent of Gag-Pol Expression (1999) (17)
Primary structure of acetylcholinesterase: implications for regulation and function. (1986) (17)
Alzheimer’s disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch–Nyhan disease) (2015) (16)
Nucleotide sequence changes in polyoma ts-a mutants: correlation with protein structure (1981) (16)
The road toward human gene therapy--a 25-year perspective. (1997) (16)
Genetic therapies, human genetic enhancement, and … eugenics? (2019) (15)
Gene therapy's new era: a balance of unequivocal benefit and unequivocal harm. (2003) (14)
Replication-defective recombinant herpes simplex virus vectors. (1994) (14)
Regions of the polyoma genome coding for T antigens. (1979) (14)
Gene therapy--a new kind of medicine. (1993) (13)
The evolving concept of gene therapy. (1990) (13)
The maturation of human gene therapy (1996) (13)
Next Generation "Omics" Approaches in the "Fight" against Blood Doping. (2017) (13)
Transduction of foreign regulatory sequences by a replication-defective herpes simplex virus type 1: the rat neuron-specific enolase promoter. (1995) (12)
Gene therapy: Fact and fiction in biology's new approaches to disease (1983) (12)
MAST‐CELL DISEASE IN CHILDREN. Report of Eleven Cases. (1967) (11)
Gene Therapy, Human (2001) (11)
The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH. (2001) (11)
Nucleotide sequence of the F protein coding region of bacteriophage phiX174 and the amino acid sequence of its product. (1978) (10)
Lessons for the Stem Cell Discourse from the Gene Therapy Experience (2005) (10)
An ASGCT Perspective on the National Academies Genome Editing Summit. (2016) (10)
Retroviral gene transfer inXenopus cell lines and embryos (1996) (10)
Medical ethics. Principles for human gene therapy studies. (2000) (10)
[2] High-efficiency gene transfer into cells (1987) (9)
Long-term transgene expression from genetically modified hepatocytes grafted to the rat liver. (1992) (9)
A fractionation method to identify qauntitative changes in protein expression mediated by IGF-1 on the proteome of murine C2C12 myoblasts (2009) (9)
Epitope insertion into the human hypoxanthine phosphoribosyltransferase protein and detection of the mutant protein by an anti-peptide antibody. (1987) (8)
Gene therapy for disorders of the nervous system. (1993) (8)
Implantation of genetically engineered cells to the brain. (1988) (8)
Differentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor. (1995) (8)
Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes. (1992) (8)
In support of mitochondrial replacement therapy (2019) (8)
Characterization of the gene delivery properties of baculoviral-based virosomal vectors. (2008) (8)
Knock-in and knock-out. Transgenes, Development and Disease: A Keystone Symposium sponsored by Genentech and Immunex, Tamarron, CO, USA, January 12-18, 1991. (1991) (7)
A mutation increasing the size of the polyoma virion proteins, VP2 and VP3. (1981) (7)
Adult mammalian hepatocyte as target cell for retroviral gene transfer: A model for gene therapy (1987) (7)
Virion proteins of polyoma temperature-sensitive mutants: late mutants. (1975) (7)
Recombination between a herpes simplex virus type 1 vector deleted for immediate early gene 3 and the infected cell genome. (1992) (7)
Genetically modified tumor-infiltrating lymphocytes for cancer therapy. (1991) (7)
Discrepant effects of culture conditions on survival and function of dopaminergic neurons (2004) (6)
Gene transfer into rat airway epithelial cells using retroviral vectors (1991) (6)
Changing roles for academia and industry in genetics and gene therapy. (2000) (6)
Provirus-anchored long-range (PAL) mapping of mammalian genomes. (1993) (5)
Preparation of pseudotyped lentiviral vectors resistant to inactivation by serum complement. (2010) (5)
Clinical gene therapy: lessons from the ether dome. (2004) (5)
A new serious adverse event in a gene therapy study. (2007) (5)
Approaches to gene therapy in disorders of purine metabolism. (1988) (4)
Milestone and events in the early development of human gene therapy. (1993) (4)
Insertion of hypoxanthine phosphoribosyltransferase cDNA into human bone marrow cells by a retrovirus. (1986) (4)
Bone Marrow Transplantation Does Not Ameliorate the Neurologic Symptoms in Mice Deficient in Hypoxanthine Guanine Phosphoribosyl Transferase (HPRT) (1999) (4)
HPRT Gene Transfer as a Model for Gene Therapy (1985) (4)
Lesch-Nyhan disease as a model for central nervous system directed gene therapy (1995) (4)
Simplified plasmid rescue of host sequences adjacent to integrated proviruses. (1996) (3)
Partial characterization of the proteome of the mouse striatum (2007) (3)
1 The Origins, Evolution, and Directions of Human Gene Therapy (1999) (3)
Gene transfer vectors for clinical application (2012) (3)
Correction: HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? (2011) (3)
origins and prospects (1993) (3)
Organization of T antigens in the polyoma virus genome. (1980) (3)
Applications and implications of genome related biotechnology. (1988) (2)
The Scientific Basis for Gene Therapy: A New Concept in Medicine (2006) (2)
834 STABILITY OF GENE TRANSFER IN LESCH NYHAN CELLS (1985) (2)
Clinical Application of Gene Transfer Technology: Overcoming the Obstacles (2005) (2)
Gene therapy for disorders of the CNS. (1994) (2)
Chromosomal sublocalization of human gene sequences by in situ hybridization (1988) (2)
Nucleotide sequence at polyoma VP1 mRNA splice sites (1981) (2)
Viral vectors do the DNA shuffle (2000) (2)
Gene Transfer In Sports: An Opening Scenario For Genetic Enhancement of Normal “Human Traits” (2006) (2)
A decade of accomplishments: gene therapy and the ASGT. (2007) (1)
In Vivo Gene Transfer with Retrovirus Vectors (1999) (1)
Gene expression from a transcriptionally disabled retroviral vector. (1986) (1)
The ASGT and ethical codes for clinical research. (2008) (1)
INSERTION OF HYPOXAKTHINE PHOSPHORIBOSYLTRANSFERASE (HPRT) cDNA INTO HUMAN BONE MARROW CELLS (BMC) A RETROVIRUS VECTOR: 75 (1985) (1)
Early Gene Transfer Experiments: Problems and Eventual Success (2006) (1)
Immunofluorescent localization of TAMM-HORSFALL mucoprotein (1966) (1)
HPRT-deficient mice: A useful new animal model for human disease (1987) (1)
ANALYSIS OF CLONED HUMAN UBIQUITOUS REPEATED DNA SEQUENCES (1980) (1)
Prospects for human gene therapy in mental retardation and developmental disabilities (1995) (1)
Genetic technology in doping and doping detection (2011) (0)
Gene Therapy: I. Strategies for Gene Therapy (1995) (0)
Abstracts of papers presented at the 1998 Meeting on Gene Therapy, September 23-September 27, 1998 (1998) (0)
Some Ethical Aspects of “Harm” in Sport (2006) (0)
Principles of gene transfer and foreign protein expression for human gene therapy (2001) (0)
531. Complexes of DNA-Cationic Liposomes with Baculovirus GP64 Envelope Fusion Protein Vesicles Demonstrate Enhanced Transfection Efficiency (2006) (0)
Preface/Front Matter (1999) (0)
The Evolution of Human Gene Therapy: A Journey from Excessive Hype to Excessive Diffidence to Reality (2007) (0)
186. Secreted Extracellular Vesicles of Baculovirus GP64 Interact with Plasmid DNA to Enhance Transfection (2005) (0)
Genetics. (Book Reviews: Genetic Interaction and Gene Transfer. Papers from a symposium, Upton, N. Y., May 1977) (1978) (0)
335. Global Transcriptional Profiles of Murine C2C12 Myoblasts Treated with IGF-1 (2006) (0)
455. Targeting of a Non-Human Coronavirus to Human Tumor Cells by Using a Bispecific Single-Chain Antibody (2003) (0)
INFORMATION TRANSFER BY CELLULAR MESSENGER RNA (1974) (0)
Modulator genes in Lesch Nyhan disease Microarray studies (2001) (0)
The development and evolution of human gene therapy (2010) (0)
Farewell to professor Shigetaka Asano. (2020) (0)
223. Proteomic Analysis of the Striatum of Wild Type and HPRT-Deficient Mouse (2006) (0)
An approach to the genetic correction of defects and disorders of the central nervous system (1992) (0)
International Cooperation and Regulation: The Banbury Workshop (2002) (2006) (0)
69 THE HPRT PROMOTER (1988) (0)
Science and society: Scientific and policy progress toward gene therapy (1985) (0)
New Retroviral Models for Gene Therapy: Swords into Plowshares (1989) (0)
Characterization of the basal and brain-specific expression of the human hypoxanthine guanine phosphoribosyltransferase gene (1996) (0)
Nucleotide Sequence atPolyoma VP1mRNA Splice Sites (2013) (0)
Ethics and Oversight in Clinical Trials: Attempts at Gene Doping Would Not Conform to Accepted Ethical Standards (2006) (0)
Temporal expression divergence of network modules (2017) (0)
An integrated funding mechanism for clinical trials in human gene therapy. (2009) (0)
Simplex Virus Type1Vectors IsDependent onItsPosition, the Infected Cell Type,andthePresence ofVmwl75 (1991) (0)
Dose-related effects of flupirtine on the pain-related evoked potential (1990) (0)
A Molecular Genetic Approach to Neuropsychiatric Disease — Some Technical and Ethical Considerations (1991) (0)
1 – Milestones and Events in the Early Development of Human Gene Therapy (1993) (0)
ORGANIZATION OF THE HUMAN HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE GENE: 101 (1985) (0)
Evidence for integration of retroviral vectors in a novel human repeat sequence (1994) (0)
A Potential Approach to Gene Therapy of Cancer (1992) (0)
Happy Anniversary. (2007) (0)
400. Transduction of Human Embryonic Stem Cells with Lentiviral Vectors: Variable Promoter Activity in Pluripotent Cells (2004) (0)
222. Aberrant Striatal Gene Expression in the Striatum of HPRT-Knockout Mouse (2006) (0)
Molecular biology and human disease: edited by Alexander Macleod and Karol Sikora, Blackwell Scientific Publications, 1984. £10.80 (xi + 271 pages) ISBN 0 632 01167 X (1985) (0)
APPENDIX I: The Nucleotide Sequence of the DNA of ϕ X174 cs 70 and the Amino Acid Sequence of the Proteins for Which It Codes (1978) (0)
CNS therapy using genetically modified cells. (1992) (0)
Approaches to Gene Therapy in the CNS: Intracerebral Grafting of Fibroblasts Genetically Modified to Secrete Nerve Growth Factor (1989) (0)
Abstracts of papers presented at the 1994 meeting on gene therapy, September 21-25, 1994 (1994) (0)
The Birth of a New Form of Medicine—Gene Therapy (2005) (0)
Inducible expression system for the generation of packaging cell lines for viral vectors pseudotyped retro (1997) (0)
The construction of the human cDNA library from RNA purified from cell line GM 637 ( Human Genetic Mutant Cell (0)
Some Issues Affecting Progress Toward Human Gene Therapy and Potential Application to the Lung (2020) (0)
Abstracts of papers presented at the 1996 Meeting on Gene Therapy, September 25-September 29, 1996 (1996) (0)
14 Targets for Gene Therapy (1999) (0)
Gene Therapy for Neurological Disease (2015) (0)
RNA Virus Vectors (2000) (0)
The successful clinical use of viral vectors for human gene therapy. Preface. (2012) (0)
AN ALTERED HPRT PROTEIN, CREATED BY AN IN VITRO MUTAGENESIS OF THE GENE, CAN BE RECOGNIZED SPECIF: CALLY BY AN ANTIPEPTIDE ANTIBODY: 235 (1985) (0)
Education, concentration and more efficient transfer of retroviral vectors pseudotyped vsv-g (1994) (0)
Scientific and policy progress toward gene therapy. (1985) (0)
Editorial Board Editorial Assistants 255 Reeeptor-mediated Gene Delivery Employing Lectin-binding Speeificity (2011) (0)
1.P.117 Gene transfer into the carotid artery using an adventitial collar comparison of the effectiveness of different gene delivery vehicles (1997) (0)
D. J. JOLLY*, H. OKAYAMAt, P. BERGt, A. C. EsTY*, D. (2016) (0)
Mechanisms of Retroviral Particle Maturation and Attachment (2003) (0)
Nucleic Acids Research Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase HI (2005) (0)
Pseudotype Formation ofMurine Leukemia Viruswith theG Protein ofVesicular Stomatitis Virus (1991) (0)
Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase (Leseh-Nyhan disease/gene cIoning/h-ansfection/DffA sequenoe analysis) (1983) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Theodore Friedmann?

Theodore Friedmann is affiliated with the following schools:

University of California, San Diego

Theodore Friedmann's Academic­Influence.com Rankings

Theodore Friedmann's Degrees

Why Is Theodore Friedmann Influential?

Theodore Friedmann's Published Works

Published Works

What Schools Are Affiliated With Theodore Friedmann?

Theodore Friedmann's AcademicInfluence.com Rankings